Stanton Continues Gradual Accumulation, Buying 6,000 Shares of Core Scientific at $16.33 Each, Signaling Steady Confidence in AI‑Driven Pivot.

Weiss Eric Stanton Buys 6,000 Shares of CORE SCIENTIFIC

Weiss Eric Stanton added 6,000 shares of Core Scientific Inc. (NASDAQ: CORZ) to his portfolio on 15 September 2026, paying $16.33 per share for a total transaction value of approximately $99,800. The purchase lifted his post‑transaction holding to 265,262 shares, or roughly 4.9 % of the company’s diluted outstanding shares. The deal was executed under a Rule 10(b)(5)(1) trading plan, indicating that Stanton had already set up a pre‑approved schedule for buying stock in the company.

Implications of the Latest Trade

Stanton’s latest purchase comes on the heels of a series of modest buys and sells that have kept his stake relatively stable. Historically, his transactions have been small relative to the company’s total shares – ranging from 7,000 shares in March and August to 18,575 shares in February – and his holdings have fluctuated between 245,000 and 265,000 shares over the past year. The most recent buy is consistent with that pattern and does not suggest a sudden change in outlook. From an investor’s perspective, the trade signals a continued, albeit cautious, confidence in Core Scientific’s long‑term prospects rather than an aggressive repositioning.

What This Means for Investors

Core Scientific’s share price has been hovering in a narrow range, with a close of $16.88 on 15 September and a 52‑week high of $30.46. The company’s price‑earnings ratio of –6.83 reflects the broader volatility of the AI‑and‑blockchain sector, where many firms are still in a growth phase. Stanton’s purchase, while modest, may reinforce the narrative that insiders see value in the company’s shift toward AI‑centric colocation services. For shareholders, this could translate into a modest upward momentum if the market interprets the insider buying as a bullish signal, especially in the context of a 3.13 % annual gain despite a recent 9.07 % decline over the month.

A Profile of Weiss Eric Stanton

Stanton’s insider activity over the past year shows a pattern of incremental, disciplined buying. His first disclosed purchase on 4 February (18,575 shares at $0.00, likely a nominal transaction) was followed by two more buys in March and August, each at prices around $14.53 to $19.19. These transactions have consistently increased his share count by roughly 7,000 shares per event, maintaining a stable ownership level near 260,000 shares. The fact that his holdings have remained above 250,000 shares for over a year suggests a long‑term investment horizon. Unlike some executives who oscillate between large buys and sells, Stanton’s pattern points to a gradual accumulation strategy rather than opportunistic trading.

Conclusion

While Weiss Eric Stanton’s latest purchase of 6,000 shares is small in dollar terms, it aligns with his historical buying cadence and demonstrates sustained confidence in Core Scientific’s evolving business model. For investors watching insider activity as a gauge of management’s view on the company’s value, Stanton’s steady accumulation reinforces a cautiously optimistic outlook amid a sector that remains highly competitive and volatile. The trade adds another data point to the narrative that Core Scientific’s pivot toward AI‑driven infrastructure may be earning a positive assessment from those with the most intimate knowledge of its operations.